These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 17202792)

  • 1. [Receptor-ligand docking simulation for membrane proteins].
    Hirokawa T
    Yakugaku Zasshi; 2007 Jan; 127(1):123-31. PubMed ID: 17202792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual Screening of Human Class-A GPCRs Using Ligand Profiles Built on Multiple Ligand-Receptor Interactions.
    Chan WKB; Zhang Y
    J Mol Biol; 2020 Aug; 432(17):4872-4890. PubMed ID: 32652079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing GPCR homology models constructed from templates of various transmembrane sequence identities: Binding mode prediction and docking enrichment.
    Loo JSE; Emtage AL; Ng KW; Yong ASJ; Doughty SW
    J Mol Graph Model; 2018 Mar; 80():38-47. PubMed ID: 29306746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficiency of Homology Modeling Assisted Molecular Docking in G-protein Coupled Receptors.
    Bhunia SS; Saxena AK
    Curr Top Med Chem; 2021; 21(4):269-294. PubMed ID: 32901584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A benchmarking study on virtual ligand screening against homology models of human GPCRs.
    Lim VJY; Du W; Chen YZ; Fan H
    Proteins; 2018 Sep; 86(9):978-989. PubMed ID: 30051928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-steered modeling and docking: A benchmarking study in class A G-protein-coupled receptors.
    Phatak SS; Gatica EA; Cavasotto CN
    J Chem Inf Model; 2010 Dec; 50(12):2119-28. PubMed ID: 21080692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
    Coudrat T; Simms J; Christopoulos A; Wootten D; Sexton PM
    PLoS Comput Biol; 2017 Nov; 13(11):e1005819. PubMed ID: 29131821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FINDSITE(comb): a threading/structure-based, proteomic-scale virtual ligand screening approach.
    Zhou H; Skolnick J
    J Chem Inf Model; 2013 Jan; 53(1):230-40. PubMed ID: 23240691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended template-based modeling and evaluation method using consensus of binding mode of GPCRs for virtual screening.
    Sato M; Hirokawa T
    J Chem Inf Model; 2014 Nov; 54(11):3153-61. PubMed ID: 25350693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design.
    Kooistra AJ; Kuhne S; de Esch IJ; Leurs R; de Graaf C
    Br J Pharmacol; 2013 Sep; 170(1):101-26. PubMed ID: 23713847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPCRs through the keyhole: the role of protein flexibility in ligand binding to β-adrenoceptors.
    Emtage AL; Mistry SN; Fischer PM; Kellam B; Laughton CA
    J Biomol Struct Dyn; 2017 Sep; 35(12):2604-2619. PubMed ID: 27532213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling G protein-coupled receptors for structure-based drug discovery using low-frequency normal modes for refinement of homology models: application to H3 antagonists.
    Rai BK; Tawa GJ; Katz AH; Humblet C
    Proteins; 2010 Feb; 78(2):457-73. PubMed ID: 19787776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of virtual screening against GPCR homology models: Impact of template selection and treatment of binding site plasticity.
    Jaiteh M; Rodríguez-Espigares I; Selent J; Carlsson J
    PLoS Comput Biol; 2020 Mar; 16(3):e1007680. PubMed ID: 32168319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interacting with GPCRs: Using Interaction Fingerprints for Virtual Screening.
    Lenselink EB; Jespers W; van Vlijmen HW; IJzerman AP; van Westen GJ
    J Chem Inf Model; 2016 Oct; 56(10):2053-2060. PubMed ID: 27626908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From heptahelical bundle to hits from the Haystack: structure-based virtual screening for GPCR ligands.
    Kooistra AJ; Roumen L; Leurs R; de Esch IJ; de Graaf C
    Methods Enzymol; 2013; 522():279-336. PubMed ID: 23374191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability of Docking-Based Virtual Screening for GPCR Ligands with Homology Modeled Structures: A Case Study of the Angiotensin II Type I Receptor.
    Chen H; Fu W; Wang Z; Wang X; Lei T; Zhu F; Li D; Chang S; Xu L; Hou T
    ACS Chem Neurosci; 2019 Jan; 10(1):677-689. PubMed ID: 30265513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Function-specific virtual screening for GPCR ligands using a combined scoring method.
    Kooistra AJ; Vischer HF; McNaught-Flores D; Leurs R; de Esch IJ; de Graaf C
    Sci Rep; 2016 Jun; 6():28288. PubMed ID: 27339552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment and challenges of ligand docking into comparative models of G-protein coupled receptors.
    Nguyen ED; Norn C; Frimurer TM; Meiler J
    PLoS One; 2013; 8(7):e67302. PubMed ID: 23844000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docking and MD study of histamine H4R based on the crystal structure of H1R.
    Feng Z; Hou T; Li Y
    J Mol Graph Model; 2013 Feb; 39():1-12. PubMed ID: 23220277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Template selection and refinement considerations for modelling aminergic GPCR-ligand complexes.
    Urmi KF; Finch AM; Griffith R
    J Mol Graph Model; 2017 Sep; 76():488-503. PubMed ID: 28818718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.